Effectiveness of Intraoperative Glenohumeral Joint Injection of Hyaluronate/Carboxymethyl cellulose in Arthroscopic Rotator Cuff Repair

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20220315007

Enrollment

Registered

2022-03-15

Start date

2022-08-05

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with rotator cuff tear requiring rotator cuff repair Hyaluronate/Carboxymethylcellulose, Arthroscopic rotator cuff repair, Postoperative shoulder stiffness

Interventions

Intraoperative Hyaluronate/Carboxymethylcellulose glenohumeral joint injection (5 ml) ,Intraoperative normal saline glenohumeral joint injection (5 ml)

Experimental Drug,Placebo Comparator Drug

Hyaluronate/Carboxymethylcellulose ,Normal saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with small-to-medium size rotator cuff tear (according to DeOrio & Cofield classification)

Exclusion criteria

Exclusion criteria: 1.Patient with history of shoulder surgery 2.Pateint who have rheumatoid arthritis 3.Pateint who have septic arthritis of the shoulder 4.Pateint who have recent or concomitant skin infection of the shoulder

Design outcomes

Primary

Measure	Time frame
Clinical. outcome : ASES score 6 months post-operation ASES score	—

Secondary

Measure	Time frame
Clinical outcomes and range of motion of shoulder joint 6 weeks, 3 months, 6 moths, 1 year post-operation Clinical outcome using ASES score, constant score, visual analog scale for pain, Range of motions of shoulder	—

Countries

Thailand

Contacts

Public ContactSupanut Klaiudom

Faculty of Medicine, Chulalongkorn University

supanut_aa@docchula.com0831770168

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026